Xiaoding Hu
Impact in
-
- Cancer-related molecular mechanisms research
-
- PARP inhibition in cancer therapy
Papers in
-
- DNA Repair Mechanisms 3
- Mechanisms of cancer metastasis 3
- Cell death mechanisms and regulation 2
- PI3K/AKT/mTOR signaling in cancer 2
- Oncology 6
- PARP inhibition in cancer therapy 3
- Co-authors
- Bisrat G. Debeb (12 shared papers)Jiaxue Wu (4 shared papers)Wendy A. Woodward (9 shared papers)Emilly S. Villodre (10 shared papers)J Wang (3 shared papers)Long Yu (4 shared papers)Juhee Song (7 shared papers)Naoto T. Ueno (7 shared papers)
- Journals
- Oncogene (3 papers)Cancer Research (3 papers)Clinical Cancer Research (1 paper)Biochemical and Biophysical Research Communications (1 paper)Dermatologic Therapy (1 paper)
- Partner nations
- United StatesChinaPuerto Rico
In The Last Decade
Xiaoding Hu
23 papers receiving 412 citations
Peers
Comparison fields: 5 of 59
- Cancer Research 97
- Oncology 120
- Molecular Biology 271
- Cell Biology 42
- Pulmonary and Respiratory Medicine 75
Countries citing papers authored by Xiaoding Hu
This map shows the geographic impact of Xiaoding Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoding Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoding Hu more than expected).
Fields of papers citing papers by Xiaoding Hu
This network shows the impact of papers produced by Xiaoding Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoding Hu. The network helps show where Xiaoding Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoding Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 55 | |
| 2 | 2018 | 42 | |
| 3 | 2017 | 41 | |
| 4 | 2021 | 35 | |
| 5 | 2021 | 33 | |
| 6 | 2021 | 27 | |
| 7 | 2017 | 27 | |
| 8 | 2017 | 27 | |
| 9 | 2017 | 27 | |
| 10 | 2015 | 26 | |
| 11 | 2020 | 24 | |
| 12 | 2021 | 14 | |
| 13 | 2015 | 13 | |
| 14 | 2013 | 7 | |
| 15 | 2024 | 5 | |
| 16 | 2021 | 4 | |
| 17 | 2020 | 3 | |
| 18 | TEMPORAL FLUCTUATIONS IN MELOIDOGYNE FUJIANENSIS PARASITIZING CITRUS RETICULATA IN NANJING, CHINA | 1999 | 1 |
| 19 | 2023 | 1 | |
| 20 | [Transdifferentiation of fibroblasts into myofibroblasts in the skin lesion of systemic sclerosis: role of transforming growth factor β1 and its signal transduction]. | 2011 | 1 |
About Xiaoding Hu
Xiaoding Hu is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 25 papers that have together received 416 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (3 papers), Mechanisms of cancer metastasis (3 papers), PARP inhibition in cancer therapy (3 papers), Brain Metastases and Treatment (3 papers), Cell death mechanisms and regulation (2 papers), Cancer Mechanisms and Therapy (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Cancer Research (97 citations), Oncology (120 citations), Molecular Biology (271 citations), Cell Biology (42 citations) and Pulmonary and Respiratory Medicine (75 citations). Xiaoding Hu has collaborated with scholars based in United States, China and Puerto Rico. Frequent co-authors include Bisrat G. Debeb, Jiaxue Wu, Wendy A. Woodward, Emilly S. Villodre, J Wang, Long Yu, Juhee Song, Naoto T. Ueno, Debu Tripathy and Savitri Krishnamurthy. Their work appears in journals such as Oncogene, Cancer Research, Clinical Cancer Research, Biochemical and Biophysical Research Communications and Dermatologic Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.